Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction.

Overview of attention for article published in Clinical Cancer Research, May 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 14 news outlets
blogs: 1 blog

twitter: 54 X users

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 33 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

Research News Roundup — May 2022

Advancing the Science , 15 Jun 2022

In May, researchers from Mayo Clinic reported gains in understanding of the benefit of AI-enabled ECGs, including from wearable…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.